#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Burkitt's lymphoma Peritoneal mesothelioma malignant Squamous cell carcinoma of the vulva Small intestine adenocarcinoma Retinopathy of prematurity Homocystinuria Neuroendocrine carcinoma metastatic Ewing's sarcoma metastatic Frostbite Conjunctivitis allergic Oropharyngeal cancer recurrent Intracranial germ cell tumour Rectal cancer Neuroendocrine tumour of the lung Progressive supranuclear palsy More trials…

    Learn about Rare Diseases

    Toxic epidermal necrolysis Hereditary hypophosphataemic rickets – Treatment Pemphigoid Mucopolysaccharidosis I – Basic Information Shprintzen-Goldberg syndrome – Trials in Disease Bronchiolitis obliterans syndrome – Life with Disease Langerhans cell sarcoma – Life with Disease Loeys-Dietz syndrome Paroxysmal nocturnal haemoglobinuria – Basic Information Undifferentiated sarcoma – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Gemcitabine Hydrochloride Bi 690517 Caraway Oil Sarilumab Quc398 Cilazapril Tezacaftor DICLOFENAC POTASSIUM Tarlatamab HYDROMORPHONE HYDROCHLORIDE Emapalumab Trandolapril Ertapenem AZD3632 Rigosertib Sodium Bepranemab Cendakimab Sar442970 BMS-986470 Ieramilimab More therapies…

    Learn about Your Condition

    Hydrocele Interstitial lung disease Retinal vein occlusion Behavioural addiction Pancreatitis chronic Sleep disorder Herpes simplex reactivation Peripheral artery stenosis Microscopic polyangiitis Glaucoma Eosinophilic oesophagitis Demyelination Prostate cancer recurrent Oxygen saturation Juvenile absence epilepsy More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Antoine Lacassagne

Centre Antoine Lacassagne

33 Avenue De Valombrose, Nice, 06189, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study Comparing FOLFOX (Oxaliplatin, Fluorouracil, Calcium Folinate) to Gemcitabine for Patients with Metastatic Pancreatic Cancer Not Suitable for FOLFIRINOX

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Adenocarcinoma pancreas
    Investigated Drugs:
    • Calcium Folinate
    • Fluorouracil
    • Gemcitabine Hydrochloride
    France

  • Study on the Effectiveness and Safety of Belinostat and Pralatrexate with Drug Combination for Newly Diagnosed Peripheral T-Cell Lymphoma Patients

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Belinostat
    • Pralatrexate
    • Cyclophosphamide
    France Germany Hungary Italy Poland Spain

  • Study of Ezabenlimab and Drug Combination for Stage III Anal Cancer Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Anal squamous cell carcinoma
    Investigated Drugs:
    • Ezabenlimab
    • Mitomycin
    • Capecitabine
    France

  • Study on Post-Operative Chemotherapy with Doxorubicin and Trabectedin for Patients with High-Risk Localized Uterine Leiomyosarcoma

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Uterine leiomyosarcoma
    Investigated Drugs:
    • Trabectedin
    • Doxorubicin Hydrochloride
    France Spain

  • Study of Dostarlimab Combined with Short Course Radiotherapy for Locally Advanced Rectal Cancer Patients with Microsatellite Instability

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Microsatellite instability cancer
    • Rectal cancer
    Investigated Drugs:
    • Dostarlimab
    France

  • Study on Reducing Chemotherapy Cycles with Pembrolizumab for Patients with PD-L1-Positive Recurrent or Metastatic Head and Neck Cancer

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Carboplatin
    • Cisplatin
    • Fluorouracil
    France

  • Study of Drug Combination Treatment Based on Tumor Molecular Changes in Patients with Advanced or Metastatic Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Neoplasm
    Investigated Drugs:
    • Siremadlin
    • Dabrafenib
    • Trametinib
    France

  • Title: Comparing tebentafusp treatment versus observation in patients with high-risk eye melanoma (uveal melanoma) after initial treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Tebentafusp
    Belgium France Germany Ireland Italy The Netherlands +3

  • Study on Stopping or Continuing Anastrozole, Letrozole, and Exemestane for Patients with Advanced or Metastatic Low-Grade Endometrial Stromal Sarcoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Letrozole
    France

  • Study Comparing mFOLFIRINOX and Capecitabine or Gemcitabine for Patients with Resected Ampullary Adenocarcinoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Tumour of ampulla of Vater
    Investigated Drugs:
    • Calcium Folinate
    • Capecitabine
    • Fluorouracil
    France
Previous Page
1 … 4 5 6 7 8 … 28
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!